No serious health effects linked to mRNA COVID-19 vaccines
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
HIV prevention treatment shows gaps among key populations
A large, detailed look by Kaiser Permanente researchers at patients taking HIV-prevention drug therapy finds strong adherence soon after patients get the prescription, but less consistent use thereafter, particularly among groups considered high priority for receiving the medication.
Predictive model paired with case management reduced rate of readmitted hospital patients
A follow-up program for Kaiser Permanente Northern California patients discharged from the hospital was associated with reduced readmissions without increased mortality, new research in the journal BMJ suggests.
For stomach cancer patients, a regionalized cancer care program can improve survival
New study describes how patients and physicians benefitted when Kaiser Permanente Northern California established a virtual, multidisciplinary gastric cancer team.
New tool for early identification of COVID-19 surges
Health systems could use data from routine clinical care to identify the onset of upcoming COVID-19 surges as many as 6 weeks before they occur, Kaiser Permanente researchers found in a study published in the journal BMJ Open.
Migraine genetics study finds intriguing connections with other medical conditions
A Kaiser Permanente genetic analysis found 82 locations on the human genome associated with migraine, 48 of them newly identified, including 3 specific to women, who experience migraine much more frequently than men.
Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19
Kaiser Permanente study found Black patients as well as patients who had obesity, liver disease, or sepsis or other signs of infection were among those more likely to be at high risk for a blood clot.
‘COVID toes’ were likely not caused by COVID-19, in most cases
Kaiser Permanente study suggests the increased incidence of chilblains — or, COVID toes — seen during pandemic was related to behavior changes, not the coronavirus.
Study identifies genetic clues for increased risk of age-related cataract
Using data from Kaiser Permanente and United Kingdom biobanks, researchers have identified new locations on the human genome that could relate to the risk of age-related cataract.
COVID-19 vaccine trial enrolls children aged 5-11 at 3 sites in Northern California
About 75 children are scheduled to receive their first vaccination against COVID-19 as part of the Pfizer/BioNTech vaccine clinical trial through Kaiser Permanente Northern California.
